Laser capture microdissection (LCM) is emerging as a premier technology with a point-and-shoot capability designed to rapidly isolate single cells or unique multicellular structures from complex ...
Understanding genomic variation in the context of cancer is paramount to identifying disease drivers and informing personalized treatment for patients. Tumor heterogeneity presents a challenge in ...
Cutting-edge dual-laser technology delivers power and precision in one device SEATTLE, Nov. 8, 2023 /PRNewswire/ -- Laxco is proud to announce the launch of the Accuva Cellect Laser Capture ...
Correlation of allele-specific HLA loss of heterozygosity in patients with cancer with driver mutations. Baseline heterogeneity of myeloid and stroma cells to predict pCR, baseline lymph node (LN) ...
A research group led by Professor Kazuki Kurimoto and Assistant Professor Hiroki Ikeda from the Department of Embryology at Nara Medical University has developed a highly sensitive method for ...
SEATTLE, Nov. 8, 2023 /PRNewswire/ -- Laxco is proud to announce the launch of the Accuva Cellect Laser Capture Microdissection (LCM) System. Our innovative system is designed to enable isolation and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results